The Economist Podcasts

Babbage: Samsung's meltdown

The Economist Podcasts

Our technology editor examines the long-term fallout after Samsung's flagship smartphone is pulled from production. The Food and Drug Administration's approval of a new drug for muscular dystrophy proves controversial and Matt Kaplan explains why higher-class people spend less time looking at their fellow humans  

See acast.com/privacy for privacy and opt-out information.

Next Episodes

The Economist Podcasts

Money talks: Flash Crash Bang Wallop @ The Economist Podcasts

📆 2016-10-12 15:46 / 00:10:43



The Economist Podcasts

The week ahead: Brexit stage right @ The Economist Podcasts

📆 2016-10-08 00:30 / 00:12:24